Pharmaceutical manufacturers of Midazolam

Sun Pharma is a global, comprehensive, specialized pharmaceutical company with production facilities for API and FDF in India, the United States, Latin America, and Europe. It produces and sells a wide range of pharmaceutical formulations as branded generics and generic drugs in India, the US, and various other global markets. It is supported by 2 advanced R&D Centers with a team of over 600 scientists for projects in Chemical Synthesis, Clinical Research, and formulation development. Sun is a frontrunner in specific therapy areas and possesses robust expertise in product development, process chemistry, and manufacturing.

R L Fine Chem Pvt. Ltd. was established in 1984 in Bengaluru and it was one of the first companies to develop and manufacture psychotropic substances in the country. In 2016, private equity groups acquired the company and are targeting a CAGR of over 20 percent for the future. The company today operates out of its 2 facilities one is at Gauribidnaur in Karnataka and the other one at Hindupur in Andhra Pradesh. Our commitment to pursue excellence and an uncompromising attitude towards quality has helped us emerge as leaders in the manufacture of psychotropic substances and APIs in other therapeutic segments such as Antipsychotics, Antihistamines, and Muscle relaxants. We are currently exporting our API to over 80 countries globally in addition to the Indian market.

Centaur Pharmaceuticals ranks among India’s few, fully integrated pharmaceutical firms with proficiencies across the pharmaceutical value chain. Centaur leverages its synergies across API, R&D, CRAM, Clinical Research and formulations to provide end-to-end solutions to prestigious pharmaceutical partners.

From removing the regular pain of fingersticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, our purpose is to make the world a better place by bringing life-changing health technologies to the people who need them. That’s our commitment to helping you live your best life.

Cambrex stands as a prominent global contract development and manufacturing organization (CDMO) delivering comprehensive analytical and IND enabling services, along with drug substance development and manufacturing throughout the entire drug lifecycle. Boasting 40 years of expertise and a workforce of 2,000 professionals catering to international clients from North America and Europe, Cambrex is a reliable ally in both the branded and generic markets for API development and manufacturing. The company provides a variety of specialized drug substance technologies and capabilities.

Fisvi is a distinguished Italian company with a proud heritage in the manufacturing and innovation sectors. Specializing in advanced materials and cutting-edge solutions, Fisvi offers a wide range of products tailored to meet the demands of various industries, including construction, automotive, and industrial applications. Their product lineup includes high-quality insulation materials, adhesives, sealants, and other specialized components designed to enhance performance and durability.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Nortec Química is the largest manufacturer of Active Pharmaceutical Ingredients (APIs) in Latin America and began its activities determined to guarantee quality medicines with APIs developed in Brazil. To this end, the company combined the knowledge of the main National Research Centers with the experience of the Brazilian Chemical and Petrochemical Industry. Nortec Química is very important in the Brazilian pharmaceutical scenario and in the Unified Health System (SUS), producing APIs for branded, generic and similar drugs and drugs for neglected diseases.

We, Precise Biopharma Pvt, seek your assistance in developing our product for the market in IRAQ. We, M/s Precise Chemipharma Pvt.Ltd, would like to present ourselves as one of the foremost Manufacturers and Exporters of Active Pharmaceutical Ingredients (API’s), Intermediates, Drug Pellets & Finished Dosage Forms

Jiangsu Nhwa Pharmaceutical Co., Ltd. was initially founded in 1978. In year 2008, Nhwa listed on the Shenzhen stock exchange with the stock code 002262. NHWA Pharma integrates R&D, production and sales together, as national psychiatric drugs designated unit, national high-tech enterprise, China’s top 100 pharmaceutical enterprises, national intellectual property rights demonstration unit, national "20 years 20 star" medical quality management enterprise star unit, international environmental certification (ISO14000) confirmed enterprise, the first batch of innovative enterprises in Jiangsu province, and vice President unit of China narcotic drug association.

Fuan Pharmaceutical (Group) Co., Ltd. commenced its operations on February 25, 2004. The organization is situated in the Chongqing Changshou Economic and Technological Development Zone, spanning an area of approximately 100 acres, with a building area exceeding 30,000 square meters, and a registered capital of 1.189 billion yuan. It stands as the inaugural company in Changshou Economic and Technological Development Zone to be successfully listed on the Shenzhen GEM (March 22, 2011, stock code: 300194). The firm oversees 9 wholly-owned and holding subsidiaries. Fuan Pharmaceutical Group Chongqing Lybon Pharm-Tech Co., Ltd was established in March 2008, specializing in pharmaceuticals.

Lake Chemicals is headquartered in Bangalore, famously referred to as the Silicon Valley of Asia, situated in the southern region of India and was established in 1992. Lake is a prominent producer of Ophthalmic and Psychotropic API’s and their intermediates.

Hameln rds s.r.o. is situated in Slovakia, a member of the European Union, in the region of Europe. It is a reputable pharmaceutical company that specializes in producing APIs and providing services for the healthcare sector, focusing on various stages of pharmaceutical product development and production, encompassing analytical and galenical development. Hameln offers a broad spectrum of services, including QC services (such as stabilities and batch release) and the development and manufacturing of APIs. Serving as a centralized API production facility, supply and trading chain, as well as a hub for research and development, Hameln rds plays a pivotal role in the pharmaceutical industry.

Cohance Lifesciences stands as a prominent CDMO and API platform, providing a wide range of products and services throughout every stage of a compound's lifespan, from its development to commercialization. Leveraging our expertise in intricate chemical processes, we deliver comprehensive CDMO services to global innovators and have successfully overseen numerous projects from inception to market launch over the years. As a global API participant, we cater to clients in approximately 60 nations, offering 80+ molecules supported by strong research and development, regulatory capabilities, and manufacturing facilities. Committed to excellence, we are one of the leading integrated exporters of pellets and possess formidable development and manufacturing capabilities.